Scar tissue to lung cancer; pathways and treatment

被引:4
|
作者
Sapalidis, Konstantinos [1 ]
Sardeli, Chrysanthi [2 ]
Pavlidis, Efstathios [1 ]
Koimtzis, Georgios [1 ]
Koulouris, Charilaos [1 ]
Michalopoulos, Nikolaos [1 ]
Mantalovas, Stylianos [1 ]
Tsiouda, Theodora [1 ]
Passos, Ioannis [1 ]
Kosmidis, Christoforos [1 ]
Giannakidis, Dimitrios [1 ]
Surlin, Valeriu [1 ]
Katsaounis, Athanasios [1 ]
Alexandrou, Vyron [1 ]
Amaniti, Aikaterini [3 ]
Zarogoulidis, Paul [1 ,2 ]
Huang, Haidong [4 ]
Li, Qiang [4 ]
Mogoanta, Stelian [5 ]
Kesisoglou, Isaac [1 ]
机构
[1] Aristotle Univ Thessaloniki, AHEPA Univ Hosp, Med Sch, Dept Surg 3, Thessaloniki, Greece
[2] Aristotle Univ Thessaloniki, Fac Hlth Sci, Sch Med, Dept Pharmacol & Clin Pharmacol, Thessaloniki, Greece
[3] Aristotle Univ Thessaloniki, AHEPA Univ Hosp, Med Sch, Anaisthisiol Dept, Thessaloniki, Greece
[4] Tongji Univ, Shanghai East Hosp, Diagnost & Therapeut Ctr Resp Dis, Shanghai, Peoples R China
[5] Univ Med & Pharm Craiova, Fac Dent, Dept Surg, Craiova, Romania
来源
JOURNAL OF CANCER | 2019年 / 10卷 / 04期
关键词
lung cancer; scar tissue; interstitial disease; fibrosis; pathways; IDIOPATHIC PULMONARY-FIBROSIS; EGFR MUTATION DETECTION; LIQUID BIOPSY; DISEASE; PNEUMONITIS; NSCLC; OSIMERTINIB; MECHANISMS; CRIZOTINIB; RESISTANCE;
D O I
10.7150/jca.30300
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Lung cancer still remains diagnosed at a late stage although we have novel diagnostic techniques at our disposal. However; for metastatic disease we have novel therapies based on pharmacogenomics. Tumor heterogenity provides us different treatments. There are several reasons for carcinogenesis; fibrosis and scar tissue provides an environment that induces malignancy. In the current review we will try and elucidate the pathways involved from scar tissue to carcinogenesis.
引用
收藏
页码:810 / 818
页数:9
相关论文
共 50 条